Food Allergy is an indication for drug development with over 80 pipeline drugs currently active. According to GlobalData, preregistered drugs for Food Allergy have a 66.67% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Food Allergy compared to historical benchmarks. Buy the report here.
Smarter leaders trust GlobalData
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Food Allergy overview
Food allergies are immune system reactions to certain proteins in food. Symptoms range from mild itching to severe anaphylaxis, involving difficulty breathing and a drop in blood pressure, which can be life-threatening. Common allergens include peanuts, tree nuts, shellfish, eggs, milk, wheat, and soy. Strict avoidance and preparedness for accidental exposure are crucial. Diagnosis involves tests like skin prick or blood tests, and management typically includes eliminating the allergen, carrying emergency medication (like epinephrine), and vigilant label reading. Seeking medical advice is crucial for proper diagnosis, management, and to create an emergency action plan.
See Also:
For a complete picture of PTSR and LoA scores for drugs in Food Allergy, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.
